- Home
- CNOBP vs SRPT Comparison
CNOBP vs SRPT Comparison
Compare CNOBP & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNOBP
- SRPT
- Stock Information
- Founded
- CNOBP N/A
- SRPT 1980
- Country
- CNOBP United States
- SRPT United States
- Employees
- CNOBP 493
- SRPT 1372
- Industry
- CNOBP Major Banks
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- CNOBP Finance
- SRPT Health Care
- Exchange
- CNOBP Nasdaq
- SRPT Nasdaq
- Market Cap
- CNOBP N/A
- SRPT 1.7B
- IPO Year
- CNOBP N/A
- SRPT 1997
- Fundamental
- Price
- CNOBP N/A
- SRPT $18.19
- Analyst Decision
- CNOBP
- SRPT Buy
- Analyst Count
- CNOBP 0
- SRPT 25
- Target Price
- CNOBP N/A
- SRPT $64.00
- AVG Volume (30 Days)
- CNOBP N/A
- SRPT 7.9M
- Earning Date
- CNOBP N/A
- SRPT 08-06-2025
- Dividend Yield
- CNOBP N/A
- SRPT N/A
- EPS Growth
- CNOBP N/A
- SRPT N/A
- EPS
- CNOBP N/A
- SRPT N/A
- Revenue
- CNOBP N/A
- SRPT $2,233,371,000.00
- Revenue This Year
- CNOBP N/A
- SRPT $26.87
- Revenue Next Year
- CNOBP N/A
- SRPT $3.15
- P/E Ratio
- CNOBP N/A
- SRPT N/A
- Revenue Growth
- CNOBP N/A
- SRPT 59.15
- 52 Week Low
- CNOBP N/A
- SRPT $16.88
- 52 Week High
- CNOBP N/A
- SRPT $155.95
- Technical
- Relative Strength Index (RSI)
- CNOBP 61.34
- SRPT 23.09
- Support Level
- CNOBP $22.61
- SRPT $16.88
- Resistance Level
- CNOBP $23.08
- SRPT $18.62
- Average True Range (ATR)
- CNOBP 0.10
- SRPT 1.40
- MACD
- CNOBP 0.00
- SRPT 0.09
- Stochastic Oscillator
- CNOBP 100.00
- SRPT 6.41
About CNOBP ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.